Skip to content
Persistent systems, Cipla, Iex and more

Indian equity benchmarks Sensex and Nifty50 started Tuesday’s session on a negative note as they trailed weakness in most other global markets. Investors generally remained cautious as they closely followed updates on the Russian-Ukrainian war.

The 30-certificate index fell 432.4 points or 0.8% to 52,410.39 in early trades and the broader benchmark Nifty50 slipped to 15,747.4, down 115 .8 points or 0.7% from its previous close.

Shares in other Asian markets started the day in the red, after Ukraine and Russia failed to reach an agreement on the creation of “humanitarian corridors” from the affected cities.

MSCI’s broadest index of Asia-Pacific stocks outside of Japan was down 0.2% at last count. Japan’s Nikkei 225 fell 0.3%, China’s Shanghai Composite 0.7%, South Korea’s KOSPI 0.5% and Singapore’s Straits Times 0.2%. The Hong Kong Hang Seng rose 0.5%.

S&P 500 futures rose 0.3%.

On Monday, all three major Wall Street indexes suffered steep declines, with the Nasdaq Composite confirming it was in a bear market. The prospect of a ban on oil imports from Russia has pushed up crude prices and fueled concerns about accelerating inflation.

CNBC-TV18’s in-house panel of experts has selected a list of stocks investors can buy/sell in trading today. Here are the best buy-sell calls from market experts:

Mitesh Thakkar from

Sell ​​Dabur India for a target of Rs 490 with a stop loss at Rs 515

Sell ​​IndusInd Bank for a target of Rs 810 with a stop loss at Rs 847

Buy Cipla for a target of Rs 960 with a stop loss at Rs 930

Buy India Cements for a target of Rs 192 with a stop loss at Rs 180

Sudarshan Sukhani from

Sell ​​Tata Motors with a stop loss at Rs 402

Buy IEX with a stop loss at Rs 201

Buy persistent systems with a stop loss at Rs 3,950

Buy LTTS with a stop loss at Rs 4,500

(Edited by : Sandep Singh)


Not all news on the site expresses the point of view of the site, but we transmit this news automatically and translate it through programmatic technology on the site and not from a human editor.